Virucidal efficacy of a novel silver-based disinfectant against SARS-CoV-2 Omicron BA.5

被引：0

作者：

Zani, Alberto ^{[1
]}

Messali, Serena ^{[1
]}

Caccuri, Francesca ^{[1
]}

机构：

[1] Univ Brescia, Dept Mol & Translat Med, Sect Microbiol, Brescia, Italy

来源：

NEW MICROBIOLOGICA | 2023年 / 46卷 / 01期

关键词：

SARS-CoV-2; Omicron BA; 5; variant; disinfectants; Silver Barrier;

D O I：

暂无

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

In this study we evaluated the antiviral activity of the Silver Barrier (R) disinfectant against SARS-CoV-2. Silver Barrier (R) showed time-and concentration-dependent antiviral activity against SARS-CoV-2. After 5 min contact time, Silver Barrier (R) at 0.002% showed a strong inhibitory effect (p < 0.001), with a 2-fold reduction of viral genome copy numbers, and a robust suppression (94%) of SARS-CoV-2 infectivity. Considering the effects obtained in solution and within a very short time, Silver Barrier (R) stands as an excellent new candidate for the disinfection of work environments, especially at the healthcare level, where there are people at high risk of serious illnesses.

引用

页码：60 / 64

页数：5

共 50 条

[21] Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa
Tegally, Houriiyah
Moir, Monika
Everatt, Josie
Giovanetti, Marta
Scheepers, Cathrine
Wilkinson, Eduan
Subramoney, Kathleen
Makatini, Zinhle
Moyo, Sikhulile
Amoako, Daniel G.
Baxter, Cheryl
Althaus, Christian L.
Anyaneji, Ugochukwu J.
Kekana, Dikeledi
Viana, Raquel
Giandhari, Jennifer
Lessells, Richard J.
Maponga, Tongai
Maruapula, Dorcas
Choga, Wonderful
Matshaba, Mogomotsi
Mbulawa, Mpaphi B.
Msomi, Nokukhanya
Naidoo, Yeshnee
Pillay, Sureshnee
Sanko, Tomasz Janusz
San, James E.
Scott, Lesley
Singh, Lavanya
Magini, Nonkululeko A.
Smith-Lawrence, Pamela
Stevens, Wendy
Dor, Graeme
Tshiabuila, Derek
Wolter, Nicole
Preiser, Wolfgang
Treurnicht, Florette K.
Venter, Marietjie
Chiloane, Georginah
McIntyre, Caitlyn
O'Toole, Aine
Ruis, Christopher
Peacock, Thomas P.
Roemer, Cornelius
Kosakovsky Pond, Sergei L.
Williamson, Carolyn
Pybus, Oliver G.
Bhiman, Jinal N.
Glass, Allison
Martin, Darren P.
NATURE MEDICINE, 2022, 28 (09) : 1785 - +
[22] BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5
Tartof, Sara Y.
Slezak, Jeff M.
Puzniak, Laura
Hong, Vennis
Frankland, Timothy B.
Ackerson, Bradley K.
Takhar, Harpreet
Ogun, Oluwaseye A.
Simmons, Sarah
Zamparo, Joann M.
Jodar, Luis
McLaughlin, John M.
LANCET INFECTIOUS DISEASES, 2022, 22 (12): : 1663 - 1665
[23] First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco
Colson, Philippe
Lavagna, Christian
Delerce, Jeremy
Groshenry, Guillaume
Yahi, Nouara
Fantini, Jacques
La Scola, Bernard
Althaus, Thomas
MICROORGANISMS, 2022, 10 (10)
[24] Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
Hachmann, Nicole P.
Miller, Jessica
Collier, Ai-ris Y.
Ventura, John D.
Yu, Jingyou
Rowe, Marjorie
Bondzie, Esther A.
Powers, Olivia
Surve, Nehalee
Hall, Kevin
Barouch, Dan H.
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (01): : 86 - 88
[25] Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
Wang, Qian
Guo, Yicheng
Iketani, Sho
Nair, Manoj S.
Li, Zhiteng
Mohri, Hiroshi
Wang, Maple
Yu, Jian
Bowen, Anthony D.
Chang, Jennifer Y.
Shah, Jayesh G.
Nguyen, Nadia
Chen, Zhiwei
Meyers, Kathrine
Yin, Michael T.
Sobieszczyk, Magdalena E.
Sheng, Zizhang
Huang, Yaoxing
Liu, Lihong
Ho, David D.
NATURE, 2022, 608 (7923) : 603 - +
[26] Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
Kimura, Izumi
Yamasoba, Daichi
Tamura, Tomokazu
Nao, Naganori
Suzuki, Tateki
Oda, Yoshitaka
Mitoma, Shuya
Ito, Jumpei
Nasser, Hesham
Zahradnik, Jiri
Uriu, Keiya
Fujita, Shigeru
Kosugi, Yusuke
Wang, Lei
Tsuda, Masumi
Kishimoto, Mai
Ito, Hayato
Suzuki, Rigel
Shimizu, Ryo
Begum, Mst Monira
Yoshimatsu, Kumiko
Kimura, Kanako Terakado
Sasaki, Jiei
Sasaki-Tabata, Kaori
Yamamoto, Yuki
Nagamoto, Tetsuharu
Kanamune, Jun
Kobiyama, Kouji
Asakura, Hiroyuki
Nagashima, Mami
Sadamasu, Kenji
Yoshimura, Kazuhisa
Shirakawa, Kotaro
Takaori-Kondo, Akifumi
Kuramochi, Jin
Schreiber, Gideon
Ishii, Ken J.
Hashiguchi, Takao
Ikeda, Terumasa
Saito, Akatsuki
Fukuhara, Takasuke
Tanaka, Shinya
Matsuno, Keita
Sato, Kei
CELL, 2022, 185 (21) : 3992 - +
[27] Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
Qian Wang
Yicheng Guo
Sho Iketani
Manoj S. Nair
Zhiteng Li
Hiroshi Mohri
Maple Wang
Jian Yu
Anthony D. Bowen
Jennifer Y. Chang
Jayesh G. Shah
Nadia Nguyen
Zhiwei Chen
Kathrine Meyers
Michael T. Yin
Magdalena E. Sobieszczyk
Zizhang Sheng
Yaoxing Huang
Lihong Liu
David D. Ho
Nature, 2022, 608 : 603 - 608
[28] Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
Tomokazu Tamura
Daichi Yamasoba
Yoshitaka Oda
Jumpei Ito
Tomoko Kamasaki
Naganori Nao
Rina Hashimoto
Yoichiro Fujioka
Rigel Suzuki
Lei Wang
Hayato Ito
Yukie Kashima
Izumi Kimura
Mai Kishimoto
Masumi Tsuda
Hirofumi Sawa
Kumiko Yoshimatsu
Yuki Yamamoto
Tetsuharu Nagamoto
Jun Kanamune
Yutaka Suzuki
Yusuke Ohba
Isao Yokota
Keita Matsuno
Kazuo Takayama
Shinya Tanaka
Kei Sato
Takasuke Fukuhara
Communications Biology, 6
[29] Structural Insight into the Resistance of the SARS-CoV-2 Omicron BA.4 and BA.5 Variants to Cilgavimab
Fujita, Shigeru
Kosugi, Yusuke
Kimura, Izumi
Yamasoba, Daichi
Sato, Kei
VIRUSES-BASEL, 2022, 14 (12):
[30] Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
Tamura, Tomokazu
Yamasoba, Daichi
Oda, Yoshitaka
Ito, Jumpei
Kamasaki, Tomoko
Nao, Naganori
Hashimoto, Rina
Fujioka, Yoichiro
Suzuki, Rigel
Wang, Lei
Ito, Hayato
Kashima, Yukie
Kimura, Izumi
Kishimoto, Mai
Tsuda, Masumi
Sawa, Hirofumi
Yoshimatsu, Kumiko
Yamamoto, Yuki
Nagamoto, Tetsuharu
Kanamune, Jun
Suzuki, Yutaka
Ohba, Yusuke
Tabata, Kaori
Yokota, Isao
Matsuno, Keita
Takayama, Kazuo
Tanaka, Shinya
Sato, Kei
Fukuhara, Takasuke
COMMUNICATIONS BIOLOGY, 2023, 6 (01)

← 1 2 3 4 5 →